US Stock Futures Up Ahead Of Earnings - GameSquare Holdings (NASDAQ:GAME), Emergent BioSolutions (NYSE:EBS)

Pre-open movers

US stock futures rose in early pre-market trade, ahead of earnings from major companies. The Chicago Fed National Activity Index for March will be released at 8:30 a.m. ET, while the Conference Board's index of leading indicators for March will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average surged 24 points to 16,367.00, while the Standard & Poor's 500 index futures gained 2.90 points to 1,860.80. Futures for the Nasdaq 100 index rose 9 points to 3,532.25.

A Peek Into Global Markets

Several European markets remained closed on Monday. European markets were higher today, with the Spanish Ibex Index rising 0.24%, London's FTSE 100 index gaining 0.62% and STOXX Europe 600 Index surging 0.26%. German DAX 30 index climbed 0.99% and French CAC 40 Index gained 0.59%. French consumer spending rose 1.4% in November. Asian markets ended mostly higher today. Japan's Nikkei Stock Average fell 0.03%, China's Shanghai Composite declined 1.52% and India's BSE Sensex rose 0.6%.

Broker Recommendation

Analysts at Nomura upgraded Morgan Stanley

from “neutral” to “buy.” The target price for Morgan Stanley has been raised from $33 to $36. Morgan Stanley's shares closed at $30.76 on Thursday.

Breaking news

TreeHouse Foods THS today announced that it will acquire Protenergy Natural Foods, an industry leading developer and manufacturer of premium quality food and beverage products, namely private label broth, soups and gravies. To read the full news, click here.
Karyopharm Therapeutics KPTI today announced the initiation of its first pediatric clinical study, a Phase 1 trial of its novel, oral Selective Inhibitor of Nuclear Export (SINE) compound Selinexor (KPT-330) in pediatric patients. To read the full news, click here.
Emergent BioSolutions EBS announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BioThrax® (Anthrax Vaccine Adsorbed) for post-exposure prophylaxis (PEP) of anthrax disease resulting from suspected or confirmed exposure to Bacillus anthracis. To read the full news, click here.
Perfect World PWRD announced that it has entered into a share purchase agreement to acquire a total of 30,326,005 class A ordinary shares of Shanda Games Limited GAME. To read the full news, click here.

Market News and Data brought to you by Benzinga APIs